The estimated Net Worth of Kevin J Reagan is at least 190 千$ dollars as of 5 December 2014. Kevin Reagan owns over 3,591 units of Bio-Techne Corp stock worth over 190,413$ and over the last 11 years Kevin sold TECH stock worth over 0$.
Kevin has made over 1 trades of the Bio-Techne Corp stock since 2014, according to the Form 4 filled with the SEC. Most recently Kevin exercised 3,591 units of TECH stock worth 254,817$ on 5 December 2014.
The largest trade Kevin's ever made was exercising 3,591 units of Bio-Techne Corp stock on 5 December 2014 worth over 254,817$. On average, Kevin trades about 1,197 units every 0 days since 2013. As of 5 December 2014 Kevin still owns at least 2,591 units of Bio-Techne Corp stock.
You can see the complete history of Kevin Reagan stock trades at the bottom of the page.
Kevin's mailing address filed with the SEC is 614 MCKINLEY PLACE N.E., , MINNEAPOLIS, MN, 55413.
Over the last 22 years, insiders at Bio-Techne Corp have traded over 37,160,097$ worth of Bio-Techne Corp stock and bought 4,361 units worth 454,370$ . The most active insiders traders include Charles R. Kummeth、Rupert Vessey、John L Higgins. On average, Bio-Techne Corp executives and independent directors trade stock every 23 days with the average trade being worth of 964,850$. The most recent stock trade was executed by Kim Kelderman on 29 August 2024, trading 1,492 units of TECH stock currently worth 99,919$.
bio-techne (formerly techne corp.), nasdaq: tech, is a global life sciences company providing innovative bioactive tools and resources for the research and clinical diagnostic communities. bio-techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. they aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. with over 275,000 products in its portfolio, bio-techne generated approximately $358 million in net sales in fy 2014 and has over 1,000 employees worldwide.
Bio-Techne Corp executives and other stock owners filed with the SEC include: